Steven G Kelsen

Title: Innovations by Steven G Kelsen in COPD Treatment

Introduction

Steven G Kelsen is an accomplished inventor based in Rydal, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of chronic obstructive pulmonary disease (COPD). With a total of 3 patents, Kelsen's work focuses on innovative methods for diagnosing and treating this debilitating condition.

Latest Patents

Kelsen's latest patents include groundbreaking methods for the treatment of COPD. One of his notable inventions involves the discovery that the plasma level of a specific panel of proteins differs between two populations: those at risk for COPD but not showing clinical symptoms, and those with very severe COPD. This significant difference in plasma levels aids in susceptibility detection, early disease detection, disease severity assessment, disease progression monitoring, and therapy efficacy monitoring. Another patent focuses on diagnosing and staging COPD based on elevated levels of extracellular H3 protein. This method utilizes the detection of histone proteins, including H3.3, H2B, H3, and H4, to provide a reliable diagnosis and treatment approach for COPD.

Career Highlights

Steven G Kelsen is affiliated with Temple University, where he continues to advance research in the medical field. His work has garnered attention for its potential to improve the lives of individuals suffering from COPD. Kelsen's innovative approaches have positioned him as a key figure in respiratory disease research.

Collaborations

Kelsen collaborates with esteemed colleagues such as Salim Merali and Carlos A Barrero, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Steven G Kelsen's contributions to the treatment of chronic obstructive pulmonary disease highlight his dedication to medical innovation. His patents reflect a commitment to improving patient outcomes through advanced diagnostic and therapeutic methods.